CFM
IDXX icon

Catalyst Funds Management’s Idexx Laboratories IDXX Stock Holding History

Catalyst Funds Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$959K Buy
+1,821
New +$1.02M 0.05% 300
2025
Q4 		– Sell
-500
Closed -$319K – 451
2025
Q3 		$319K Hold
500
– – 0.05% 319
2025
Q2 		$268K Buy
+500
New +$239K 0.07% 274

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Catalyst Funds Management's IDXX Position: Q2 2026 in Review

Catalyst Funds Management opened a new position in Idexx Laboratories (IDXX) in Q2 2026: 1,821 shares worth $959K. The stake represents 0.05% of the portfolio and ranks #300 among its holdings. This is a return to the name: Catalyst Funds Management previously reported a position in IDXX as recently as Q3 2025.

Catalyst Funds Management first reported a position in IDXX in Q2 2025 and has held it in 3 quarters since. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Catalyst Funds Management held 1,821 shares of Idexx Laboratories worth $959K as of Q2 2026.
  • Idexx Laboratories was a new Catalyst Funds Management position in Q2 2026.
  • Idexx Laboratories made up 0.05% of Catalyst Funds Management's portfolio in Q2 2026, its #300 holding.
  • Catalyst Funds Management first reported a position in Idexx Laboratories in Q2 2025 and has held it in 3 quarters since.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Catalyst Funds Management's 13F filing for Q2 2026, filed 10 Aug 2026.